Literature DB >> 17043161

Cardiovascular effects of nonproteolytic activation of prorenin.

Dinko Susic, Howard Lippton, Martha Knight, Edward D Frohlich.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17043161     DOI: 10.1161/01.HYP.0000247309.36509.7b

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  6 in total

Review 1.  Prorenin/renin receptor, signals, and therapeutic efficacy of receptor blocker in end-organ damage.

Authors:  Tadashi Inagami; Atsuhiro Ichihara
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 2.  Prorenin and the (pro)renin receptor in ocular pathology.

Authors:  Jennifer L Wilkinson-Berka
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

3.  Prorenin/renin receptor blockade promotes a healthy fat distribution in obese mice.

Authors:  Paul Tan; Carolane Blais; Thi M-D Nguyen; Peter W Schiller; Jolanta Gutkowska; Julie L Lavoie
Journal:  Obesity (Silver Spring)       Date:  2016-07-26       Impact factor: 5.002

4.  The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling.

Authors:  Sandra Feldt; Ulrike Maschke; Ralf Dechend; Friedrich C Luft; Dominik N Muller
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 5.  Autophagy and the (Pro)renin Receptor.

Authors:  Katrina J Binger; Dominik N Muller
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-21       Impact factor: 5.555

Review 6.  Involvement of (pro)renin receptor in the glomerular filtration barrier.

Authors:  Atsuhiro Ichihara; Mariyo Sakoda; Asako Kurauchi-Mito; Yuki Kaneshiro; Hiroshi Itoh
Journal:  J Mol Med (Berl)       Date:  2008-03-12       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.